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Abstract
Background: The M2 phenotype of tumor-associated macrophages (TAM) inhibits the anti-tumor inflammation,
increases angiogenesis and promotes tumor progression. The transcription factor Nuclear Factor (erythroid-derived
2)-Like 2 (Nrf2) not only modulates the angiogenesis but also plays the anti-inflammatory role through inhibiting
pro-inflammatory cytokines expression; however, the role of Nrf2 in the cancer cell and macrophages interaction is
not clear.
Methods: Hepatocellular carcinoma cells (Hep G2 and Huh 7) and pancreatic cancer cells (SUIT2 and Panc-1) were
co-cultured with monocytes cells (THP-1) or peripheral blood monocytes derived macrophages, then the phenotype
changes of macrophages and epithelial-mesenchymal transition of cancer cells were detected. Also, the role of Nrf2 in
cancer cells and macrophages interaction were investigated.
Results: In this study, we found that cancer cells could induce an M2-like macrophage characterized by up-regulation
of CD163 and Arg1, and down-regulation of IL-1b and IL-6 through Nrf2 activation. Also, Nrf2 activation of macrophages
promoted VEGF expression. The Nrf2 activation of macrophages correlated with the reactive oxygen species induced by
cancer cells derived lactate. Cancer cells educated macrophages could activate Nrf2 of the cancer cells, in turn, to increase
cancer cells epithelial-mesenchymal transition (EMT) through paracrine VEGF. These findings suggested that Nrf2 played
the important role in the cancer cells and macrophages interaction.
Conclusions: Macrophage Nrf2 activation by cancer cell-derived lactate skews macrophages polarization towards an M2-
like phenotype and educated macrophages activate Nrf2 of the cancer cells to promote EMT of cancer cells. This study
provides a new understanding of the role of Nrf2 in the cancer cell and TAM interaction and suggests a
potential therapeutic target.
Keywords: Nuclear factor (erythroid-derived 2)-like 2, Tumor-associated macrophage, Hepatocellular carcinoma,
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Background
The tumor microenvironment, mainly consisted of extra-
cellular matrix, fibroblasts, vascular endothelial cells and
immunocytes, plays an important role in tumor structure
and biology, contributing tumor cells survival, proliferation
and migration [1]. Macrophages are attracted and activated
by tumor microenvironment derived cytokines, differ-
entiating into tumor-associated macrophages (TAMs)
and contributing to complicating inflammation conditions
[2]. It has indicated that TAMs were multifunctional and
heterogeneous [3]. The one phenotype of TAMs shows the
pro-inflammatory characteristic is identified as classical or
M1 macrophages, which secret IL-1 and IL-6; the other
phenotype owns anti-inflammatory capability referred to
alternative or M2 macrophages, which mainly express Arg1
and CD163 [4]. The current studies have shown that higher
amount of M2 TAMs was associated with worse clinical
prognosis [5–7]. A higher density of M2 TAMs appears
to correlate with tumor cell proliferation, metastasis,
and intra-tumoral microvascular density [8, 9].
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Nuclear factor (erythroid-derived 2)-like 2 (Nrf2), which
is essential for keeping the balance of oxidative stress, has
been known to improve cell survival under threaten of
xenobiotic toxicants through initiating anti-oxidative genes
transcription [10]. Without stimulation, Nrf2 binds
with two molecules of Keap-1 and is subsequently pro-
teasomal degraded. Oxidative stressors or electrophiles
dissociates the Nrf2 from Keap-1, prevents Nrf2 from
degrading and increases nuclear accumulation of Nrf2.
Also, Nrf2 has been shown to favor the progression,
chemo- and radio-resistance of several types of cancers
[11–13]. Previous studies have demonstrated that Nrf2
could directly inhibit the inflammatory cytokines transcrip-
tion of immune cells and indirectly limit the inflammatory
process through modulating HO-1 expression [14, 15].
However, the role of Nrf2 in TAM formation and its
function on cancer cell is unclear.
In this study, THP-1 or peripheral blood monocyte
(PBMC) derived macrophages and cancer cells co-
stimulation was performed to mimic the cancer cell
and macrophages interaction in the tumor microenvir-
onment. We found that Nrf2 was essential for driving
macrophage activation into M2 phenotype by cancer
cell stimulation and migration of cancer cell.
Methods
Cell culture and treatment
The hepatocellular carcinoma cell lines Hep G2 and Huh
7 were gotten from the Riken Cell Bank (Tsukuba, Japan).
Pancreatic cancer cell lines Panc-1 was gotten from the
Riken Cell Bank, and SUIT2 was gotten from Japanese
Collection of Research Bio-resources Cell Bank (Ibaraki,
Japan). These cell lines were passaged for fewer than
6 months after resuscitation. Cancer cells were cultured in
DMEM (Life Technologies Japan Ltd., Tokyo, Japan) con-
taining 10% FBS (Life Technologies Japan Ltd., Tokyo,
Japan). Human monocyte cell line, THP-1, gotten from
Culture Collections of Public Health England, grew in
RPMI-1640 (Wako, Osaka, Japan) containing 10%FBS and
10 mM HEPES. THP-1 cells were treated with 150 nM
phorbol-12-myristate-13-acetate (PMA) (Sigma, St. Louis,
MO, USA) for 48 h to induce to macrophages.
Cells were transfected with Nrf2 siRNA (Applied
Biosystems, s9492, Waltham, Massachusetts, USA), Keap-1
siRNA (Applied Biosystems, s18981, Waltham, MA, USA)
or negative control siRNA (Applied Biosystems, Select
Negative Control #1 siRNA, Waltham, MA, USA) at
10 nmol/L using Lipofectamine 2000 (Invitrogen, Thermo
Fisher Scientific Inc., Waltham, MA, USA) according to
the manufacturer’s instructions.
Conditioned medium (CM) of cells preparing
The cells were washed with pre-warmed PBS twice,
then incubated with the FBS-free medium. After 24 h
of incubation, the medium was collected, centrifuged
(450×g, 5 mins) and filtrated by the 0.2 μm filter. The
conditioned medium was used without additional FBS
supplemented.
Migration assay
The transwell inserts (Corning, NY. USA) with 8 μm
pore size were used for migration assay. 0.5-1 × 105 can-
cer cells were seeded in the upper chamber. After cell
attached, the upper chambers were washed twice with
DMEM gently, then the medium of upper chambers was
changed to conditioned medium, and the same medium
with 5% FBS supplemented was used in the lower cham-
ber. After 24 h incubation, the cells on the downside of
transwell inserts were fixed in 4% paraformaldehyde and
stained with 0.2% crystal violet. The stained cells in five
random × 400 microscopic fields were counted.
Lactate assay
The concentration of lactate in the conditioned medium
was measured by using lactate assay kit (Sigma, St.
Louis, MO, USA). The 10ul fresh conditioned medium
was mixed with lactate assay buffer. Then 50ul of the
master reaction mix was added to each sample. After in-
cubating the reaction for 30 min at room temperature,
measure the absorbance at 570 nm.
Reactive oxygen species (ROS) detection
The cells were incubated with 2′, 7′-Dichlorofluorescin
diacetate (H2DCFDA 5 μM, Sigma) 30 min. Then the
cells were washed and received the stimulation of condi-
tioned medium for 6 h. The fluorescence intensity (λex =
495/λem = 529 nm) was measured by the plate reader
(SpectraMax i3, Molecular Devices, Tokyo, Japan).
Enzyme-linked immunosorbent assay
The level of IL-1, IL-6 and VEGF were detected by using
IL-1, IL-6 and VEGF Quantikine ELISA kit (R&D Sys-
tems, Minneapolis, MN, USA) according to the manufac-
turer’s protocol. Absorbance at 450 nm was measured
using a plate reader as a correction wavelength of 540 nm.
Polymerase chain reaction
The total RNA of each sample was extracted using the
RNeasy Mini Kit (Qiagen, Hilden, Germany) according to
the manufacturer’s instructions. cDNA was synthesized
using the reverse transcription kit (Applied Biosystems,
Thermo Fisher Scientific Inc., Waltham, MA, USA). The fol-
lowing primers from TaqMan gene expression assays (assay
identification number) were used: IL-1b (Hs01555410_m1);
IL-6 (Hs00174131_m1); CD163 (Hs00174705_m1); Arg1
(Hs00163660_m1) and VEGF-α (Hs00163660_m1). GAPDH
(4352339E) was selected as internal control. StepOnePlus
Real-Time PCR System (Applied Biosystems, Thermo Fisher
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Scientific Inc., Waltham, MA, USA) was used to per-
form qRT-PCR.
Western blotting
Nuclear and cytoplasmic proteins were extracted by
using NuCLEAR™ Extraction Kit (Sigma, St. Louis, MO,
USA). Total proteins were extracted by lysing cell with
RIPA buffer (Thermo Fisher Scientific Inc., Waltham,
MA, USA) containing the protease inhibitor cocktail
(Sigma, St. Louis, MO, USA) and PhosSTOP phos-
phatase inhibitor cocktail (Roche, Tokyo, Japan). Then
Proteins concentration were measured with the BCA
kit (Thermo Fisher Scientific Inc., Waltham, MA, USA),
and equal amounts of extracted proteins separated on 10%
SDS-PAGE gels and transferred onto PVDF membranes
(Bio-Rad, Hercules, CA, USA). Membranes were incubated
with the indicated primary antibody, then appropriate
HRP-conjugated secondary antibody. The proteins were
detected with Chemiluminescence (GE, Little Chalfont,
Buckinghamshire, UK). The primary antibodies used in
western blotting were listed in Table 1.
Tumor cell transplantation
Six to eight-week-old BALB/c nude mice were pur-
chased from Charles River Company (Yokohama, Japan)
and housed at the animal center of Tokushima University.
All animal experiments were approved by Tokushima
University Institutional Review Board. The experiments
performed in accordance with the guidelines of the
Animal Research Committee of Tokushima University
Graduate School. To establish the animal model, 250ul
of Panc-1 and Huh 7 (2 × 107 cells/ml) containing 50%
matrigel matrix (Corning, NY. USA) with or without
educated macrophages (2 × 105 cells) was injected sub-
cutaneously. After four weeks, the mice were sacrificed
and tumor tissues were collected.
Immunochemistry
The cells were washed with cold PBS and fixed with
paraformaldehyde. Then the fixed cells were incubated
with anti-Nrf2 primary antibody overnight at 4 °C. Then
after fluorophore-conjugated second antibody incubation,
the cells were observed. The xenograft tumor tissues,
which paraformaldehyde –fixed and paraffin-embedded,
were incubated with primary monoclonal antibody CD163
(ab87099, Abcam, Tokyo, Japan) and Nrf2 (ab62352,
Abcam, Tokyo, Japan). After incubated with the
fluorophore-conjected second antibody, the slides were
checked by fluorescence microscope (Keyence Corpor-
ation, Itasca, IL, USA).
Statistical analysis
Data were presented as mean ± SD. Statistical analyses
were performed by SPSS 19.0 (IBM, NY, USA). The stu-
dent t-test was used to compare the difference between
the two groups. One-way analysis of variance (one-way
ANOVA) followed by Bonferroni’ test was used to com-
pare the differences more than two groups. There was a
statistically significant difference when the p-value was
less than 0.05.
Results
Cancer cells induced macrophages phenotype
transformation
After stimulated with PMA 48 h, the suspended THP-1
attached the dishes and differentiated into macrophages
(M0) [16]. Then the M0 macrophages were stimulated
with CM of hepatocellular carcinoma cells (Hep G2 and
Huh 7) and pancreatic carcinoma cells (Panc-1 and
SUIT2) for another 24 h (Fig. 1a). After CM stimulation,
the tumor educated macrophages (TEM) decreased the
expression of M1 macrophage markers, such as IL-1b,
IL-6 and increased the expression of M2 macrophage
markers including Arg1 and CD163 compared with M0
macrophage. Also, the VEGF-α was up-regulated after
education (Fig. 1b). As the same as THP-1 derived mac-
rophages, the human peripheral blood monocyte
(PBMC) derived macrophages increased M2 macrophage
markers and VEGF expression after CM of cancer cells
stimulation (Additional file 1: Figure S1A).
Nrf2 activation correlated with M2 TEM formation and
VEGF-α expression
It has been reported that Nrf2 played the important role
in the anti-inflammatory action [17]. Over-activation of
Nrf2 could inhibit the pro-inflammatory cytokines expres-
sion [15]. In order to uncover whether the Nrf2 partici-
pated in the TEM phenotype transformation, Nrf2
expression of TEM was detected firstly. The immuno-
fluorescent staining of Nrf2 demonstrated that the Nrf2
nuclear translocation of TEM apparently increased com-
pared with M0 macrophages (Fig. 1c). Also, compared
with the nuclear Nrf2 of M0, nuclear Nrf2 of TEM had an
obviously higher level (Fig. 1d). HO-1 and Nqo-1, as the
downstream genes of Nrf2, increased after cancer cell CM
stimulation (Fig. 1e). The Nrf2 levels were also detected in
PBMC derived TEM. Similar to THP-1 derived TEM,
PBMC derived TEM also showed an increase of Nrf2 nu-
clear translocation (Additional file 1: Figure S1B-C). The
Table 1 The first antibody used in western blot
Name Product number Company
Histone H3 antibody #9715 Cell Signaling
b-Actin antibody #4967 Cell Signaling
N-cadherin antibody #13116 Cell Signaling
Nrf2 antibody ab62352 Abcam
E-cadherin antibody ab1416 Abcam
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xenograft tumor tissues of cancer cells and THP-1 derived
TEM co-injection and patients’ tumor tissues showed that
CD163-positive cells were also characterized as high Nrf2
nuclear-translocation (Additional file 1: Figure S1D-E).
Above all, it has been demonstrated that Nrf2 was
over-activated in the TEM by cancer cell CM stimulation.
To confirm the correlation between Nrf2 activation and
TEM phenotype transformation, Nrf2 knocked-down of
THP-1 derived M0 macrophage was performed by small
interfering RNA treatment (Fig. 2a). The Nrf2 knocked-
down was also verified by Nrf2 downstream genes expres-
sion (Additional file 1: Figure S2A). Nrf2 knock-down of
macrophage canceled the effect of cancer cell CM which
induced M1 macrophage markers down-regulation and
M2 macrophage markers up-regulation (Fig. 2b-c and
Additional file 1: Figure S2B). Moreover, Nrf2 knock-
down diminished the cancer cell CM-induced VEGF-α
expression and secretion (Fig. 2b-c).
Keap-1 mediated Nrf2 degradation is the dominating





Fig. 1 Cancer cells induced macrophages phenotype transformation and Nrf2 activation. a THP-1 cells were incubated with PMA (150 nM) 48 h
to induced macrophage and then stimulated with cancer cell CM (scale bar 200 μm). b after 24 h stimulation with the CM of Panc-1 (Panc-CM),
SUIT 2 (SUIT-CM), Hep G2 (Hep-CM) and Huh 7 (Huh-CM) or cultured with normal medium (Ctrl), the genes expressions of macrophages were
detected by PCR analysis (n = 4). c, after 24 h stimulation with the CM of Panc-1 (Panc-CM), SUIT 2 (SUIT-CM), Hep G2 (Hep-CM) and Huh 7 (Huh-CM)
or cultured with normal medium (Ctrl), Nrf2 of TEMs and M0 macrophage (red) was stained (scale bar 100 μm) (n = 3). d the nuclear and cytoplasm
Nrf2 of TEM were detected by western blot. e the expression of downstream genes of Nrf2 (HO-1 and Nqo-1) were analyzed by PCR analysis (n = 4).
Graphs show the data as mean ± SD. *, P < 0.05, compared with ctrl
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receives stimulation, Nrf2-Keap-1 complex disassembles
and Nrf2 translocates into nuclear. Keap-1 knocked-down
was utilized to manipulate the Nrf2 activation. Increased
Nrf2 nuclear accumulation and Nrf2-dependent transcrip-
tion were confirmed after Keap-1 knocked-down (Fig. 2a
and Additional file 1: Figure S2A). Keap-1 knocked-down
amplified M2-macrophages induction by cancer cells,
appearing as decreased IL-1b and IL-6 expression, and in-
creased CD163 and Arg1 expression (Fig. 2d-e and Add-
itional file 1: Figure S2B). The application of Diethyl maleate
(DEM), a small molecule Nrf2 activator, was also confirmed
that Nrf2 activation of macrophages enhanced cancer
cell-induced M2 macrophages transformation and VEGF-α
expression [15] (Fig. 2f-g and Additional file 1: Figure S2B).
Lactate secreted by cancer cell promoted TEM Nrf2
activation
Our data revealed that the cancer cell CM activated Nrf2 in
macrophage correlated with M2 features of TEM, we next
sought to identify the tumor-derived soluble factor(s) which
was capable of Nrf2 activation. Firstly, to determine the na-
ture of cancer cell secreted factors that alter macrophage
subtype, the cancer cell conditioned medium was subjected
to three freeze-thaw cycles (− 80 °C, 60 °C). We found that
CM of the cancer cell with or without processing both
could increase M2 feature of TEM indicating that the fac-
tor(s) lacked tertiary structure (Fig. 3a). It meant that pro-
teins which achieved functions relying on the tertiary and
quaternary structure were excluded [19]. So, small molecule
metabolites could be the candidates. The well-known
Warburg effect demonstrates that lactate would be
highly produced by cancer cell through aerobic glycoly-
sis even at normoxia condition [20]. Oxalic acid was
the one of LDH inhibitor which converted pyruvate to
lactate [21]. To verify whether lactate in cancer cell CM
correlated with the Nrf2 activation of TEM, we reduced
the lactate in cancer cell CM by pre-incubated the cancer
cell with the oxalic acid containing media (Fig. 3b). It
showed that the lactate-reduced CM of cancer cells lost the







Fig. 2 Nrf2 activation was correlated with M2 TEM formation and VEGF-α expression. a the siRNA of Nrf2 and Keap-1 and DEM were used to pre-
modulate Nrf2 activation. The nuclear Nrf2 were detected by western blotting. b the M1/2 macrophages markers of Nrf2 knocked-down (si-Nrf2) were
detected after cancer cell CM stimulation (n = 4). c 24-h secretion of IL-1, IL-6 and VEGF of Nrf2 knocked-down TEM were evaluated by ELISA (n = 3).
d the M1/2 macrophages markers of Keap-1 knocked-down (si-Keap-1) were detected after cancer cell CM stimulation (n = 4). e IL-1, IL-6 and VEGF
concentration of Keap-1 knocked-down (si-Keap-1) TEM were evaluated by ELISA (n = 3). f M0 macrophages were pre-treated with 100-mM DEM for
6 h before cancer cell CM stimulation, the M1/2 macrophages markers were detected by PCR (n = 4). g, IL-1, IL-6 and VEGF concentration of DEM pre-
treated (DEM) were evaluated by ELISA (n = 3). Graphs show the data as mean ± SD. *, P < 0.05, compared with si-Neg or ctrl
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which could be rescued by exogenous lactate supplement
(3 mM) (Fig. 3c-d). However, the exogenous hydrochloric
acid which could also decrease the pH value as lactate
could not promote the Nrf2 activation of macrophages
(Data were not showed). Concomitantly, lactate-reduced
CM of cancer cell failed to induce TEM phenotype
transformation until exogenous lactate added (Fig. 3e-f
and Additional file 1: Figure S3A-B).
ROS formation regulated by lactate activated Nrf2
In the previous results, we confirmed that the lactate de-
rived from the cancer cell activated the Nrf2 of TEM and
induced its M2 feature. However, the detail of the Nrf2
activation of TEM by lactate is unknown. It had been
reported that lactate stimulation could increase the
intercellular ROS [22]. In our study, the fluorescence
intensity of 2′,7′-dichlorofluorescein (DCF) showed
that normal cancer cell CM significantly up-regulated
intracellular ROS level of macrophage comparing with
the lactate reduced ones or without cancer cell CM
stimulation (Fig. 4a). Also, as Fig. 4a showed, exogenous
lactate could recover the ROS level as normal cancer cell
CM-induced. Above all, it confirmed that the lactate in
the cancer cell CM was responsible for ROS formation in
TEM. In the canonical pathways, Nrf2 activation is re-





Fig. 3 Lactate derived from cancer cells induced macrophages transformation through regulating Nrf2 activation. a macrophages were
stimulated with cancer cell CM which subjected to three freeze-thaw cycles (− 80 °C, 60 °C), and the expressions of M1/2 macrophages markers
were detected by PCR (n = 4). b cancer cells were incubated with oxalic acid (OA) (30 mM) 3 days before conditioned medium prepared. The
lactate concentrations of cancer cell CM were measured (n = 3). c nuclear Nrf2 of macrophages were detected after cultured with normal
medium (Ctrl) or stimulated with the normal cancer cell CM (CM), oxalic acid pre-treated cancer cell CM (OA), or exogenous lactate supplement
contained oxalic acid pre-treated cancer cell CM (OA + LA). d HO-1 and Nqo-1 expression of TEM after stimulated with the normal cancer cell CM
(Ctrl), oxalic acid pre-treated cancer cell CM (OA), or exogenous lactate supplement contained oxalic acid pre-treated cancer cell CM (OA + LA)
were analyzed by PCR (n = 4). e M1/2 macrophage markers expression of TEM after stimulated with the normal cancer cell CM (Ctrl), oxalic acid
pre-treated cancer cell CM (OA), or exogenous lactate supplement contained oxalic acid pre-treated cancer cell CM (OA + LA) were detected by
PCR (n = 4). f 24-h secretion of IL-1, IL-6 and VEGF of TEM stimulated with the normal cancer cell CM (Ctrl), oxalic acid pre-treated cancer cell CM
(OA), and exogenous lactate supplement contained oxalic acid pre-treated cancer cell CM (OA + LA) were measured by ELISA (n = 3). Graphs
show the data as mean ± SD. *, P < 0.05, compared with ctrl. N.S., no significant between two groups
Feng et al. Cell Communication and Signaling  (2018) 16:54 Page 6 of 12
whether Nrf2 activation in TEM relied on lactate-induced
ROS or not, we inhibited the ROS formation in macro-
phages during cancer cell CM stimulation by NAC treat-
ment (Fig. 4b). NAC treatment canceled the Nrf2 nuclear
accumulation which appeared after cancer cell CM
stimulation (Fig. 4c). Moreover, ROS inhibition dimin-
ished the macrophage phenotype remodeling (Fig. 4d-e





Fig. 4 Lactate elevated intracellular ROS of macrophages to induce M2 TEM formation through Nrf2. a macrophages were incubated with 2′,7′-
dichlorodihydrofluorescein diacetate (H2DCFDA) for 30 mins, then stimulated with FBS-free medium (Neg Ctrl), the normal cancer cell CM (Ctrl),
oxalic acid pre-treated cancer cell CM (OA), or exogenous lactate supplement contained oxalic acid pre-treated cancer cell CM (OA + LA) for
another 6 h, the fluorescent intensity of 2′,7′-dichlorofluorescein (DCF) were detected (n = 4). b macrophages were incubated with 2′,7′-
dichlorodihydrofluorescein diacetate (H2DCFDA) for 30 mins, then stimulated with normal cancer cell CM with (NAC) or without NAC (Ctrl). The
fluorescent intensity of 2′,7′-dichlorofluorescein (DCF) was detected (n = 4). c the nuclear Nrf2 of macrophages after stimulation by cancer cell CM
with or without NAC was measured by western blot. d M1/2 macrophages markers expression of TEM induced by cancer cell CM or cancer cell
CM and NAC (n = 4). e 24-h secretion of IL-1, IL-6 and VEGF of macrophages stimulated by cancer cell CM with or without NAC (n = 3). Graphs
show the data as mean ± SD. *, P < 0.05, compared between two groups or with ctrl. N.S., no significant between two groups
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TEM activated Nrf2 of cancer cells to promote cancer cell
EMT
In the CD163 and Nrf2 double staining of mice xeno-
graft tumor tissues, the Nrf2 nuclear translocation could
be observed not only in CD163-positive cells but also in
the cancer cells around the CD163 positive macrophages
(Fig. 5a). In the patients’ tumor tissues, the nuclear Nrf2
positive cancer cells could also observe near the CD163
positive cells (Additional file 1: Figure S4A). In order to
uncover that whether the Nrf2 activation of cancer cells
correlated with CD163-positive macrophages stimulation
or not, we stimulated cancer cells with CM of TEM or
M0 macrophages in vitro. The higher Nrf2 nuclear accu-
mulation of cancer cell was detected after stimulation
with CM of TEM both derived from THP-1 or PBMC
(Fig. 5b and Additional file 1: Figure S4B). It has been
reported that Nrf2 activation could promote cancer me-
tastasis by modulating epithelial-mesenchymal transition
(EMT) [24]. Nrf2 knocked-down in cancer cells before
TEM CM stimulation was performed to illustrate the re-
lationship between TEM-induced cancer cell Nrf2 acti-
vation and EMT (Fig. 5c-d and Additional file 1: Figure.
S4C-D). The migration assay showed that TEM CM
significantly increased the cancer cell migration com-
pared with M0-CM. However, Nrf2 knocked-down of
cancer cell blunted the TEM migration-promoting effect
(Fig. 5e and Additional file 1: Figure S4E). After TEM
CM stimulation, the morphological changes of cancer
cells resembling EMT were clearly observed on normal
cancer cells but not on Nrf2 knocked-down ones, with
cells becoming spindle-shaped and scattered compared
to cobble stone-shaped (Fig. 5f and Additional file 1:
Figure S4F). Moreover, the EMT related markers ex-
pression revealed that TEM promoted cancer cell EMT
through Nrf2 activation, as Nrf2 knocked-down dimin-
ished the TEM modulated EMT expression (Fig. 5g and
Additional file 1: Figure S4G).
TEM derived VEGF stimulated cancer cell EMT through
Nrf2 activation
Based on the previous report, VEGF could increase can-
cer cell proliferation, migration ability [25]. Considering
that previous results showed M0 macrophages and Nrf2
knock-down TEM, both of which had lower VEGF ex-
pression than normal TEM, partly lost cancer cell
migration-promoting ability, VEGF might be a candi-
date responsible for TEM induced cancer cell EMT.
VEGF neutralization by the anti-VEGF antibody (R&D
Systems, Minneapolis, MN, USA) canceled the cancer
cell migration-promoting effect of TEM CM was de-
tected (Fig. 6a and Additional file 1: Figure S5A). The
morphological changes as characteristic of EMT van-
ished when the VEGF was neutralized (Fig 6b and
Additional file 1: Figure S5B). The EMT markers
expression of cancer cell also showed that VEGF reduc-
tion attenuated the EMT promoting-effect of educated
macrophage (Fig. 6c and Additional file 1: Figure S5C).
Also, VEGF neutralization in educated macrophage condi-
tioned medium could not induce the Nrf2 activation and
Nrf2-dependent transcription (Fig. 6d-e and Additional
file 1: Figure S5D-E). Above all, it demonstrated that TEM
derived VEGF stimulated cancer cell EMT through Nrf2
activation.
Discussion
In this study, we described a new role of Nrf2, relevant
for cancer-induced macrophages phenotype transform-
ation and paracrine action of TAM on cancer cell EMT.
Our study demonstrated the existence of a cross-talk be-
tween macrophages and cancer cells. Cancer cells secreted
lactate, which elevated ROS in macrophages, induced
macrophage M2 phenotype transformation and VEGF ex-
pression through Nrf2 mediation. On the other hand,
cancer cell educated macrophages promoted cancer cell
migration partially relied on the increased Nrf2 activation
of cancer cell by VEGF secretion (Fig. 6f).
Peripheral blood monocytes are recruited and acti-
vated to form a wide spectrum of TAM in response to
chemokines and growth factors to construct the tumor
microenvironment [2]. In the tumor microenvironments,
there are not only IFN-γ, TNF-a, and GM-CSF which
could activate macrophages like M1 macrophages, but
also IL-4, IL-10 and CSF-1 which induce M2 macro-
phages differentiation [26]. In our study, the cancer cells
provoked M2 phenotype as demonstrated by an increase
of CD163 and Arg1 and a decrease of IL-1b and IL-6
expression. The CD163+ or M2 macrophage, as a prog-
nosis factor, induce the cancer progression including
cancer cell proliferation, migration and invasion, and
angiogenesis [5, 27, 28].
Nrf2, a key regulator for the maintenance of redox
homeostasis, has been demonstrated to contribute to cell
proliferation and malignant phenotypes [29, 30]. Previ-
ous decades, the role of Nrf2 in immune modulation
have been recognized. As our study showed Nrf2 activa-
tion in macrophages inhibited the IL-1b and IL-6 expres-
sion, it has been demonstrated that activation of Nrf2
prevented LPS-induced upregulation of pro-inflammatory
cytokines, including IL-1b and IL-6 [15]. IL-1b and IL-6
production are increased in Nrf2−/− mice with dextran
sulfate-induced colitis [31]. Moreover, Nrf2 could affect
macrophage polarization toward the M2 phenotype
through its downstream genes HO-1 [32]. Consistent
with our study, Nrf2 activation in macrophage increased
M2 markers including CD163 and Arg1 expression. How-
ever, some reports showed that Nrf2-deficient myeloid lin-
eages but not Nrf2 wild-type could increase lung cancer
metastasis in vivo [33, 34]. In these studies, the Nrf2 of
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myeloid-derived cells but not macrophage were modu-
lated. It might be related with the pro-differentiation ac-
tion of Nrf2 on myeloid lineages which affect anti-tumor
immune cell formation [35].
The Warburg effect widely exists among the cancer cells
provide cancer cell production for nucleotide, amino acids
and lipids for proliferation [36, 37]. The Warburg effect








Fig. 5 TEM activated Nrf2 of cancer cells was correlated with cancer cell EMT. a the tumor tissue of mice xenograft model stained with CD163
(green), Nrf2 (red) and DAPI (blue) (scale bar 100 μm) (n = 4). b nuclear Nrf2 of cancer cell was measured after stimulated with FBS-free medium
(Ctrl), CM of M0 macrophages (M0-CM) or TEM (TEM-CM) by western blotting. c nuclear Nrf2 level of cancer cells after Nrf2 knocked down
(si-Nrf2) and stimulated with TEM-CM or M0 CM were detected by western blotting. d the HO-1 and Nqo-1 expression of cancer cells were
detected by PCR (n = 4). e the migrated cells of normal stimulated with M0 CM (M0-CM) and TEM CM (TEM-CM) and Nrf2 knocked down cancer
cell stimulated with TEM CM (TEM-CM + si-Nrf2) were observed and counted (scale bar 100 μm) (n = 3). f the cancer cell morphology changes
were observed after 24 h incubation with the M0 CM (M0-CM), TEM CM (TEM-CM) or Nrf2 knockdown followed TEM CM (TEM-CM + siNrf2)
(scale bar 50 μm). g E-cadherin and N-cadherin expression of normal and Nrf2 knocked down cancer cell were detected by western blot, after
24 h incubation with the M0 CM (M0-CM), TEM CM (TEM-CM) or Nrf2 knockdown followed TEM CM (TEM-CM + siNrf2). Graphs show the data as
mean ± SD. *, P < 0.05, compared between two groups
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only regulate the pH level but also modulate the inflam-
mation of the tumor microenvironment [38, 39]. Lactate
can suppress TLR-4 mediated inflammation in the liver
and pancreatic tissue [40]. Also, it has been reported that
lactate induces M2 like macrophages through HIF-1a
mediation [41]. G protein-coupled receptor 132 is a
stress-inducible transmembrane receptor that responses
to lactate but not the acidic condition related to M2
macrophage transformation by Nrf2 activation [42]. Al-
though no certain study was reported the relation between
lactate and Nrf2, there is the indirect evidence in which






Fig. 6 TEM derived VEGF stimulated cancer cell EMT through Nrf2 activation. a the migrated cancer cell stimulated with CM of TEM with
(TEM-CM + anti-VEGF) or without (TEM-CM + IgG) VEGF neutralization were observed and counted (scale bar 100 μm) (n = 3). b the cancer cell
morphology changes were observed after stimulated with CM of TEM with (TEM-CM + anti-VEGF) or without (TEM-CM + IgG) VEGF neutralization
(scale bar 50 μm). c E-cadherin and N-cadherin expression of cancer cell stimulated with CM of TEM with (TEM-CM + anti-VEGF) or without
(TEM-CM + IgG) VEGF neutralization were detected by western blotting. d nuclear Nrf2 of cancer cell was measured after stimulated with CM of
TEM with (TEM-CM + anti-VEGF) or without (TEM-CM + IgG) VEGF neutralization were detected by western blotting. e HO-1 and Nqo-1 expression
of cancer cells were detected by qPCR after stimulated with CM of TEM or VEGF neutralized (anti-VEGF) CM of TEM (n = 4). f The working model
of how the cancer cells and macrophages interaction. Graphs show the data as mean ± SD. *, P < 0.05
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as a Nrf2 activator, or HIF-1a which is usually reciprocal
activation of Nrf2 show the clues of the relationship of lac-
tate and Nrf2 [43].
Our results also implied that the Nrf2 over-activation
in the tumor was necessarily associated with TAM pro-
mote migration through induced EMT. The association of
Nrf2 and cancer malignancy has been previously shown.
The previous analyses of Nrf2 expression or activation in
human tumors have revealed that high Nrf2 expression or
activation correlated with poor prognosis in hepatocellular
carcinoma and pancreatic cancer [44, 45]. Actually, Nrf2
not only maintains cancer cell growth at oxidative stress,
but also increase the cancer cell invasion potential
through downregulated E-cadherin expression [13, 46].
The effect of VEGF on cancer cell migration and invasion
has been reported decades ago [47]. With the anti-VEGFR
treatment wildly performed in the clinical, VEGF-VEGFR
induced cancer metastasis is further noticed. The associ-
ation of VEGF and Nrf2 activation expression has been
reported in Kweider’s study in which VEGF activated the
Nrf2 in an ERK1/2-dependent manner [48]. Hypoxia due
to Nrf2 activation can regulate HIF-1α/VEGF signaling
pathways to modulate angiogenesis [49]. In addition, Nrf2
knockdown significantly decreased VEGF expression [50].
Our results demonstrated that TEM derived VEGF could
activate Nrf2 activation in the cancer cell.
Conclusions
In conclusion, lactate derived from cancer cells stimulate
macrophages M2 phenotype transformation through
Nrf2 activation. TEM secrete VEGF to promote cancer
cell migration by Nrf2 induced EMT. These findings not
only cover the cancer cell and macrophages interaction
to contribute to tumor progression but also provides
comprehensive insights into the role of Nrf2 in TAM
formation and tumor metastasis.
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